gdufa ii (9/28) generic drugs forum 2017
Published 4 years ago • 816 plays • Length 19:43Download video MP4
Download video MP3
Similar videos
-
20:23
preparing for gdufa ii user fees (6/28) generic drugs forum 2017
-
23:46
gdufa regulatory science research update (5/28) generic drugs forum 2017
-
14:47
office of pharmaceutical quality policy update (4/28) generic drugs forum 2017
-
16:07
development of single, shared system rems (10/28) generic drugs forum 2017
-
20:47
generic drug product quality review (23/28) generic drugs forum 2017
-
31:13
keynote – office of pharmaceutical quality (2/28) generic drugs forum 2017
-
14:56
drug substance review - anda (22/28) generic drugs forum 2017
-
15:59
opq communications with industry (21/28) generic drugs forum 2017
-
17:16
ectd (7/28) generic drugs forum 2017
-
17:35
fda’s bioequivalence recommendations for generic drugs (16/28) generic drugs forum 2017
-
17:19
gdufa ii – review timelines (14of27) generic drugs forum 2018
-
31:44
keynote – office of generic drugs (1/28) generic drugs forum 2017
-
17:24
rpm communications associated with “take action” process (15/28) generic drugs forum 2017
-
20:50
facility evaluation and inspection (26/28) generic drugs forum 2017
-
15:00
filing review – do’s and don’ts (14/28) generic drugs forum 2017
-
19:24
anda policy and regulatory considerations prior to filing (12/28) generic drugs forum 2017
-
34:57
panel discussion (8/28) generic drugs forum 2017
-
23:06
gdufa ii pre-anda program meetings: advice for success (10of27) generic drugs forum 2018
-
19:20
review of clinical endpoint bioequivalence studies in andas (17/28) generic drugs forum 2017